Page last updated: 2024-11-12

tetramic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tetramic acid : A gamma-lactam that is 1,3-dihydro-2H-pyrrol-2-one in which the hydrogen at position 4 has been replaced by a hydroxy group. Despite its simple structure, it was not synthesised until 1972; earlier attempts were later shown to have resulted only in the formation of the isomer 5-imino-4,5-dihydrofuran-3-ol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID54687243
CHEMBL ID92167
MeSH IDM0054134

Synonyms (20)

Synonym
CHEMBL92167
2h-pyrrol-2-one, 1,5-dihydro-4-hydroxy-
tetramic acid
5-hydroxy-1,2-dihydropyrrol-3-one
AKOS006356772
503-83-3
1,5-dihydro-4-hydroxy-2h-pyrrol-2-one
A828093
4-hydroxy-1h-pyrrol-2(5h)-one
AKOS015898076
4-hydroxy-2,5-dihydro-1h-pyrrol-2-one
DTXSID30198308
79469-69-5
3-hydroxy-1,2-dihydropyrrol-5-one
FT-0714591
F14818
mfcd13194923
Q15632820
5-hydroxy-1h-pyrrol-3(2h)-one
CS-0311627
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (137)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.46)18.7374
1990's3 (2.19)18.2507
2000's38 (27.74)29.6817
2010's78 (56.93)24.3611
2020's16 (11.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (6.47%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other130 (93.53%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]